Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Identification of genes regulating TRAIL-induced apoptosis in rheumatoid arthritis fibroblasts-like synoviocytes

Genes & Immunity volume 16, pages 462–469 (2015)Cite this article

Subjects

Abstract

We previously described that sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis varied in rheumatoid arthritis fibroblasts-like synoviocytes (RAFLS) from one patient to another and was correlated with disease severity. Therefore, we screened for genes differentially expressed in RAFLS sensitive and resistant to TRAIL-induced apoptosis. The sensitivity of RAFLS was defined based on the percentage of TRAIL-induced apoptosis: 0–10% for resistant cells and >25% for sensitive RAFLS. We performed transcriptomic comparison between RAFLS-S (n=6) and RAFLS-R (n=6) and then examined the implication of identified candidates in the regulation of apoptosis using small interference RNA (siRNA). Microarray analysis revealed 10 functional genes differentially expressed according to TRAIL sensitivity. These factors are implicated in different functions, such as the respiratory chain (ND3), the transport of lipids (OSBP2, PLTP), the regulation of signaling linked to extracellular factors (SULF2, GALNT1, SIAE) or the regulation of gene expression (TET2 and LARP6). We confirmed differential expression for GALNT1 and LARP6 by quantitative reverse transcriptase–PCR. Using siRNA extinction, we demonstrated the implication of GALNT1, SULF2 and LARP6 in the control of TRAIL-induced responses. These results are of particular interest as GALNT1 and LARP6 have been implicated in the regulation of cell death and may represent interesting targets to induce apoptosis of RAFLS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

Gene Expression Omnibus

References

  1. Wang S, El-Deiry WS . TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 2003; 22: 8628–8633.

    Article  CAS  Google Scholar 

  2. Johnstone RW, Frew AJ, Smyth MJ . The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 2008; 8: 782–798.

    Article  CAS  Google Scholar 

  3. Di Pietro R, Zauli G . Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L. J Cell Physiol 2004; 201: 331–340.

    Article  CAS  Google Scholar 

  4. Screaton G, Xu XN . T cell life and death signalling via TNF-receptor family members. Curr Opin Immunol 2000; 12: 316–322.

    Article  CAS  Google Scholar 

  5. Secchiero P, Gonelli A, Carnevale E, Milani D, Pandolfi A, Zella D et al. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 2003; 107: 2250–2256.

    Article  Google Scholar 

  6. Secchiero P, Zerbinati C, Rimondi E, Corallini F, Milani D, Grill V et al. TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. Cell Mol Life Sci 2004; 61: 1965–1974.

    Article  CAS  Google Scholar 

  7. Ehrhardt H, Fulda S, Schmid I, Hiscott J, Debatin KM, Jeremias I . TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene 2003; 22: 3842–3852.

    Article  CAS  Google Scholar 

  8. Baader E, Toloczko A, Fuchs U, Schmid I, Beltinger C, Ehrhardt H et al. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects. Cancer Res 2005; 65: 7888–7895.

    Article  CAS  Google Scholar 

  9. Pope RM . Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2002; 2: 527–535.

    Article  CAS  Google Scholar 

  10. Morel J, Audo R, Hahne M, Combe B . TNF-related apoptosis ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through MAP kinases and PI3 kinase/Akt. J Biol Chem 2005; 280: 15709–15718.

    Article  CAS  Google Scholar 

  11. Audo R, Calmon-Hamaty F, Baeten D, Bruyer A, Combe B, Hahne M et al. Mechanisms and clinical relevance of TRAIL-triggered responses in synovial fibroblasts of rheumatoid arthritis patients. Arthritis Rheum 2011; 63: 904–913.

    Article  CAS  Google Scholar 

  12. Audo R, Combe B, Coulet B, Morel J, Hahne M . The pleiotropic effect of TRAIL on tumor-like synovial fibroblasts from rheumatoid arthritis patients is mediated by caspases. Cell Death Differ 2009; 16: 1227–1237.

    Article  CAS  Google Scholar 

  13. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C . A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39–51.

    Article  CAS  Google Scholar 

  14. Audo R, Deschamps V, Hahne M, Combe B, Morel J . Apoptosis is not the major death mechanism induced by celecoxib on rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2007; 9: R128.

    Article  Google Scholar 

  15. Goellner S, Steinbach D, Schenk T, Gruhn B, Zintl F, Ramsay E et al. Childhood acute myelogenous leukaemia: association between PRAME, apoptosis- and MDR-related gene expression. Eur J Cancer 2006; 42: 2807–2814.

    Article  CAS  Google Scholar 

  16. Solary E, Bernard OA, Tefferi A, Fuks F, Vainchenker W . The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia 2014; 28: 485–496.

    Article  CAS  Google Scholar 

  17. Bousquet-Antonelli C, Deragon JM . A comprehensive analysis of the La-motif protein superfamily. RNA 2009; 15: 750–764.

    Article  CAS  Google Scholar 

  18. Cai L, Fritz D, Stefanovic L, Stefanovic B . Binding of LARP6 to the conserved 5' stem-loop regulates translation of mRNAs encoding type I collagen. J Mol Biol 2010; 395: 309–326.

    Article  CAS  Google Scholar 

  19. Weber-Boyvat M, Zhong W, Yan D, Olkkonen VM . Oxysterol-binding proteins: functions in cell regulation beyond lipid metabolism. Biochem Pharmacol 2013; 86: 89–95.

    Article  CAS  Google Scholar 

  20. Valavanis C, Wang Z, Sun D, Vaine M, Schwartz LM . Acheron, a novel member of the Lupus Antigen family, is induced during the programmed cell death of skeletal muscles in the moth Manduca sexta. Gene 2007; 393: 101–109.

    Article  CAS  Google Scholar 

  21. Shao R, Scully SJ Jr., Yan W, Bentley B, Mueller J, Brown C et al. The novel lupus antigen related protein acheron enhances the development of human breast cancer. Int J Cancer 2012; 130: 544–554.

    Article  CAS  Google Scholar 

  22. Sun RJ, Wang QY, Zhang JB, Guo YF, Zhao XD . [Regulation of proliferation and apoptosis of human vascular endothelial cell by Acheron]. Zhonghua Shao Shang Za Zhi 2011; 27: 156–160.

    CAS  PubMed  Google Scholar 

  23. Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med 2007; 13: 1070–1077.

    Article  CAS  Google Scholar 

  24. Stern HM, Padilla M, Wagner K, Amler L, Ashkenazi A . Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab. Clin Cancer Res 2010; 16: 1587–1596.

    Article  CAS  Google Scholar 

  25. Hakomori S, Handa K . Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy. FEBS Lett 2002; 531: 88–92.

    Article  CAS  Google Scholar 

  26. Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, Pintzas A . Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther 2007; 6: 2591–2599.

    Article  CAS  Google Scholar 

  27. Song JH, Tse MC, Bellail A, Phuphanich S, Khuri F, Kneteman NM et al. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. Cancer Res 2007; 67: 6946–6955.

    Article  CAS  Google Scholar 

  28. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324.

    Article  CAS  Google Scholar 

  29. Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg A, Peterson C . BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 2002; 3 SOFTWARE0003.

    Article  Google Scholar 

  30. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.

    Article  Google Scholar 

  31. Smyth GK, Speed T . Normalization of cDNA microarray data. Methods 2003; 31: 265–273.

    Article  CAS  Google Scholar 

  32. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, W Huber (eds). Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer: New York, USA, 2005, pp 397–420.

  33. Lutfalla G, Uze G . Performing quantitative reverse-transcribed polymerase chain reaction experiments. Methods Enzymol 2006; 410: 386–400.

    Article  CAS  Google Scholar 

  34. Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402–408.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Professor Chammas and Canovas for providing synovial tissues. We also thank the ‘MGX-Montpellier GenomiX’ for transcriptomic analysis and statistics. This work was supported by the Association pour la Recherche sur le Cancer, the Société Française de Rhumatologie and the Arthritis Foundation Courtin.

Author information

Authors and Affiliations

  1. Department of Rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France

    R Audo, B Combe & J Morel

  2. Institut de Génétique Moléculaire de Montpellier, CNRS, UMR, Montpellier, 5535, France

    R Audo, A Hegglin, B Combe, M Hahne & J Morel

  3. MGX-Montpellier GenomiX, Montpellier, France

    D Severac & C Dantec

  4. Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    M Hahne

Authors
  1. R Audo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Hegglin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Severac
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Dantec
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Combe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Hahne
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Morel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Morel.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Audo, R., Hegglin, A., Severac, D. et al. Identification of genes regulating TRAIL-induced apoptosis in rheumatoid arthritis fibroblasts-like synoviocytes. Genes Immun 16, 462–469 (2015). https://doi.org/10.1038/gene.2015.31

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gene.2015.31

This article is cited by

Search

Advanced search

Quick links